Mohammad Algahtani

ORCID: 0000-0002-0398-6712
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Mechanisms and Therapy
  • Angiogenesis and VEGF in Cancer
  • Cancer, Hypoxia, and Metabolism
  • Bioactive Compounds and Antitumor Agents
  • Hemoglobinopathies and Related Disorders
  • Drug Transport and Resistance Mechanisms
  • Iron Metabolism and Disorders
  • Cancer, Lipids, and Metabolism
  • Cancer-related Molecular Pathways
  • Electrochemical sensors and biosensors
  • Glioma Diagnosis and Treatment
  • Autism Spectrum Disorder Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Blood disorders and treatments
  • Chronic Myeloid Leukemia Treatments
  • Platelet Disorders and Treatments
  • Antibiotics Pharmacokinetics and Efficacy
  • Saffron Plant Research Studies
  • Cerebral Venous Sinus Thrombosis
  • IL-33, ST2, and ILC Pathways
  • Cancer Research and Treatments
  • Nigella sativa pharmacological applications
  • Biochemical Analysis and Sensing Techniques
  • Lanthanide and Transition Metal Complexes
  • Chemotherapy-induced organ toxicity mitigation

King Saud University
2019-2024

Security Forces Hospital
2019-2023

Nova Southeastern University
2017-2022

Taif University
2022

University of Tabuk
2022

Imam Mohammad ibn Saud Islamic University
2021

King Abdulaziz Medical City
2020

Pharmac
2020

National Guard Health Affairs
2020

Southeastern University
2017

As we navigate the modern era, intersection of time-honoured natural remedies and contemporary scientific approaches forms a burgeoning frontier in global healthcare. For generations, products have been foundational to health solutions, serving as primary healthcare choice for 80% 85% world's population. These herbal-based, nature-derived substances, significant across diverse geographies, necessitate renewed emphasis on enhancing their quality, efficacy, safety. In current century, advent...

10.1016/j.biopha.2023.116083 article EN Biomedicine & Pharmacotherapy 2023-12-31

Multiple sclerosis (MS) is an immune-mediated inflammatory disease that leads to demyelination and neuronal loss in the central nervous system. Immune cells of lymphoid myeloid origin play a significant role initiation amplification inflammation MS. STAT3 signaling plays pivotal both immune cells, such as neutrophils CD4+ T through regulation their potential. Dysregulation cell compartments has been reported In this report, we attempted investigate effect small molecular inhibitor STAT3,...

10.3390/pharmaceutics13070925 article EN cc-by Pharmaceutics 2021-06-22

Gastric ulcer (GU) is a lesion in the gastric mucosa associated with excessive oxidative damage, inflammatory response, apoptotic events, and irritation which may develop into cancer. However, medications commonly used GU treatment cannot normalize mucosa, while causing several adverse effects. Proanthocyanidins (PAs) are dietary flavonoids numerous biological pharmacological activities. In current investigation, we studied potential anti-ulcerative activity of PAs against acidified ethanol...

10.1111/jfbc.14070 article EN Journal of Food Biochemistry 2022-01-16

In the present work, an attempt was undertaken to improve oral bioavailability and anticancer activity of abiraterone acetate. Solid lipid nanoparticles (SLNs) were developed using quality by design (QbD) principles evaluated through in vitro, ex vivo, vivo studies. suitability equilibrium solubility study, while surfactant cosurfactant screened based on ability form microemulsion with selected lipid. SLNs prepared emulsion/solvent evaporation method glyceryl monostearate, Tween 80,...

10.1021/acsomega.1c07254 article EN cc-by-nc-nd ACS Omega 2022-05-10

Objective: To propose a theoretical formulation of engeletin-nanostructured lipid nanocarriers for improved delivery and increased bioavailability in treating Huntington's disease (HD). Methods: We conducted literature review the pathophysiology HD limitations currently available medications. also reviewed potential therapeutic benefits engeletin, flavanol glycoside, through Keap1/nrf2 pathway. then proposed across blood-brain barrier (BBB) bioavailability. Results: is an autosomal dominant...

10.3389/fphar.2023.1218625 article EN cc-by Frontiers in Pharmacology 2023-07-10

Sepsis affects millions of people worldwide and is associated with multiorgan dysfunction that a major cause increased morbidity mortality. several morbidities, such as lung, liver, central nervous system (CNS) dysfunction. Sepsis-associated CNS usually leads to mental problems including depression. IL-17A one the crucial cytokines expressed secreted by Th17 cells. cells are reported be involved in pathogenesis depression anxiety humans animals. One protein tyrosine kinases plays key role...

10.3390/ijms24098101 article EN International Journal of Molecular Sciences 2023-04-30

The plant Trigonella foenum-graecum, well-known as fenugreek, has been shown to control type-2 diabetes, the level of cholesterol, inflammation wounds, disorders related gastrointestinal tracts, and cancer well. present study aimed evaluate anti-cancer potential methanolic fenugreek seed extract (FSE) its possible molecular mechanism action in breast cells.The anticancer FSE was evaluated MCF-7 SK-BR3 cells through various cellular assays after selecting IC10, IC25, IC35, IC50 doses by cell...

10.2147/jir.s300025 article EN cc-by-nc Journal of Inflammation Research 2021-04-01

Dasatinib is an effective treatment for chronic myeloid leukemia. However, cases of idiosyncratic hepatotoxicity were reported. This study was conducted to investigate the chemopreventive effects hydroxychloroquine against dasatinib-induced hepatotoxicity. Balb/c mice randomly assigned into four groups; vehicle control (5% DMSO, i.p., n = 6), dasatinib (50 mg/kg; (10 mg/kg, and + mg/kg 50 6). Treatments given once every 2 days 14 days. Serum histopathological assessments liver architecture...

10.1177/09603271231188492 article EN cc-by-nc Human & Experimental Toxicology 2023-03-01

Non-small cell lung carcinoma is a challenging disease worldwide. This study aims to determine whether combining erlotinib, an epidermal growth factor receptor (EGFR) inhibitor, with cabozantinib, mesenchymal-epithelial transition (c-Met) would have augmented therapeutic benefit on A549 cells. The combination of erlotinib and cabozantinib (5 µM) inhibited viability compared each monotherapy at ≥ 10 µM as confirmed by the MTT assay. Combination therapy also has more potent inhibition cellular...

10.1016/j.jsps.2023.101756 article EN cc-by-nc-nd Saudi Pharmaceutical Journal 2023-08-24

Background Globally, iron-deficiency anemia (IDA) remains a major health obstacle. This condition has been identified in 47% of pre-school students (aged 0 to 5 years), 42% pregnant females, and 30% non-pregnant females 15 50 years) worldwide according the WHO. Environmental genetic factors play crucial role development IDA; testing revealed association number polymorphisms with iron status serum ferritin. Aim The current study aims reveal TMPRSS6 rs141312 BMP2 rs235756 Saudi Arabia. Methods...

10.1371/journal.pone.0257895 article EN cc-by PLoS ONE 2021-11-15
Coming Soon ...